Revertant mosaicism in skin: natural gene therapy
- 1 March 2011
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 17 (3) , 140-148
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Mitotic Recombination in Patients with Ichthyosis Causes Reversion of Dominant Mutations in KRT10Science, 2010
- Somatic mosaicism in the Wiskott–Aldrich syndrome: Molecular and functional characterization of genotypic revertantsClinical Immunology, 2010
- Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndromeBlood, 2008
- Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1)Blood, 2008
- Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3Journal of Clinical Investigation, 2007
- Hypomorphic Mutations in the Gene Encoding a Key Fanconi Anemia Protein, FANCD2, Sustain a Significant Group of FA-D2 Patients with Severe PhenotypeThe American Journal of Human Genetics, 2007
- Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cellsNature Medicine, 2006
- Mosaicism of NK cells in a patient with Wiskott-Aldrich syndromeBlood, 2005
- Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome familyBlood, 2004
- Revertant Mosaicism in Epidermolysis Bullosa Caused by Mitotic Gene ConversionCell, 1997